Later on, full-blown AML emerges upon accumulation of additional mutations (second hit) in NPM1 or in the FLT3 and NRAS signalling pathways in the pool of expanded pre-leukaemic HSCs. The gene discussed is NPM1; the disease is acute myeloid leukemia.